Volume 30, Supplement—October 2024
SUPPLEMENT ISSUE
Articles
Genomic Epidemiology of Multidrug-Resistant Escherichia coli and Klebsiella pneumoniae in Kenya, Uganda, and Jordan
Table
Variable | Escherichia coli, no. (%) |
Klebsiella pneumoniae, no. (%) |
|||||
---|---|---|---|---|---|---|---|
Kenya, n = 430 | Uganda, n = 207 | Jordan, n = 148 | Kenya, n = 97 | Uganda, n = 69 | Jordan, n = 212 | ||
Age groups, y | |||||||
0–4 | 7.2 (31) | 1.9 (4) | 19.6 (29) | 7.2 (7) | 7.2 (5) | 26.9 (57) | |
5–9 | 1.9 (8) | 0 | 5.4 (8) | 0 | 1.4 (1) | 4.7 (10) | |
10–17 | 2.1 (9) | 3.4 (7) | 4.1 (6) | 3.1 (3) | 0 | 4.2 (9) | |
18–49 | 61.4 (264) | 67.6 (140) | 22.3 (33) | 60.8 (59) | 58 (40) | 22.6 (48) | |
>50 | 27.4 (118) | 24.2 (50) | 45.9 (68) | 28.9 (28) | 27.5 (19) | 41.5 (88) | |
Not available |
0 |
2.9 (6) |
2.7 (4) |
0 |
5.8 (4) |
0 |
|
Sex | |||||||
M | 47.4 (204) | 37.7 (78) | 59.5 (88) | 60.8 (59) | 56.5 (39) | 75.0 (159) | |
F | 51.9 (223) | 62.3 (129) | 40.5 (60) | 39.2 (38) | 42.0 (29) | 25.0 (53) | |
Not available |
0.7 (3) |
0 |
0 |
1.4 (1) |
0 |
||
Infection type | |||||||
CAI | 81.4 (350) | 48.8 (101) | 48.0 (71) | 68.0 (66) | 33.33 (23) | 14.2 (30) | |
HAI | 15.8 (68) | 42.5 (88) | 52.0 (77) | 28.9 (28) | 56.52 (39) | 85.8 (182) | |
Not available |
2.8 (12) |
8.7 (18) |
0 |
3.1 (3) |
10.14 (7) |
0 |
|
Year of isolation | |||||||
2011 | 0 | 0 | 0 | 0 | 0 | 0.5 (1) | |
2012 | 0 | 0 | 6.8 (10) | 0 | 0 | 9.0 (19) | |
2013 | 0 | 1.0 (2) | 16.2 (24) | 0 | 0 | 14.2 (30) | |
2014 | 0 | 0 | 18.2 (27) | 0 | 0 | 7.1 (15) | |
2015 | 7.7 (33) | 10.1 (21) | 26.4 (39) | 4.1 (4) | 7.2 (5) | 34.0 (72) | |
2016 | 4.2 (18) | 9.7 (20) | 21.6 (32) | 3.1 (3) | 21.7 (15) | 21.2 (45) | |
2017 | 7.4 (32) | 7.7 (16) | 3.4 (5) | 10.3 (10) | 10.1 (7) | 10.8 (23) | |
2018 | 25.6 (110) | 5.8 (12) | 4.1 (6) | 29.9 (29) | 5.8 (4) | 0.9 (2) | |
2019 | 19.8 (85) | 4.3 (9) | 3.4 (5) | 17.5 (17) | 5.8 (4) | 2.4 (5) | |
2020 | 6.7 (29) | 13.5 (28) | 0 | 5.2 (5) | 7.2 (5) | 0 | |
2021 | 15.3 (66) | 22.2 (46) | 0 | 21.6 (21) | 30.4 (21) | 0 | |
2022 |
13.3 (57) |
25.6 (53) |
0 |
8.2 (8) |
11.6 (8) |
0 |
|
Sample type | |||||||
Wound/skin | 49.1 (211) | 10.6 (22) | 11.5 (17) | 71.1 (69) | 2.9 (2) | 0.9 (2) | |
Urine | 39.3 (169) | 57.5 (119) | 34.5 (51) | 20.6 (20) | 39.1 (27) | 11.8 (25) | |
Blood | 0.2 (1) | 1.0 (2) | 20.3 (30) | 0.0 | 2.9 (2) | 20.8 (44) | |
Pus | 8.4 (36) | 29.5 (61) | 0 | 7.2 (7) | 43.5 (30) | 0 | |
Throat | 0.5 (2) | 0 | 0 | 0 | 0 | 0 | |
Respiratory | 0.0 (2) | 0 | 33.8 (50) | 0 | 2.9 (2) | 66.5 (141) | |
Other | 2.1 (9) | 1.4 (3) | 0 | 1.0 (1) | 8.7 (6) | 0 | |
Not available | 0.5 (2) | 10.6 (22) | 0 | 0 | 0 | 0 |
* CAI, community-acquired infection; HAI, healthcare-associated infection.
Page created: October 30, 2024
Page updated: November 11, 2024
Page reviewed: November 11, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.